Caveolin-1 expression is associated with plaque formation in hypercholesterolemic rabbits

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 8, 2006, Pages 897-904

  Lin, Wei Wen ^a,b   Lin, Yu Chun ^a   Chang, Ti Yu ^b   Tsai, Shu Huai ^a   Ho, Hon Chun ^a,b   Chen, Ying Tsung ^b   Yang, Vivian C ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Atheroma; Caveolin 1; Hypercholesterolemia; Nitric oxide synthase activity; Smooth muscle cell proliferation

Indexed keywords

CAVEOLIN 1; NITRIC OXIDE SYNTHASE; STRUCTURAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTERY WALL; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAVEOLA; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; CAVEOLIN 1; CELL PROLIFERATION; CHOLESTEROL; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE III; RABBITS; TIME FACTORS; TUNICA INTIMA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33746308366     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.5A6869.2006     Document Type: Article

References (41)

1. Boger RH, Bode-Boger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC (1995) Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117:273-284
2. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6:1362-1367
3. Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, et al. (1994) Purification and characterization of smooth muscle cell caveolae. J Cell Biol 126:127-138
4. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-2452
5. Drexler H (1999) Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 43:572-579
6. Elias JM, Margiotta M, Gaborc D (1989) Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 92:62-67
7. Feron O, Dessy C, Desager JP, Balligand JL (2001) Hydroxymethylglutaryl- coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103:113-118
8. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897-905
9. Feron O, Kelly RA (2001) The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ Res 88:129-131
10. Fielding CJ, Bist A, Fielding PE (1997) Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 94:3753-3758
11. Fielding CJ, Fielding PE (1997) Intracellular cholesterol transport. J Lipid Res 38:1503-1521
12. Fielding PE, Fielding CJ (1996) Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae. Biochemistry 35:14932-14938
13. Fielding PE, Russel JS, Spencer TA, Hakamata H, Nagao K, Fielding CJ (2002) Sterol efflux to apolipoprotein A-I originates from caveolin-rich microdomains and potentiates PDGF-dependent protein kinase activity. Biochemistry 41:4929-4937
14. Frank PG, Galbiati F, Volonte D, Razani B, Cohen DE, Marcel YL, Lisanti MP (2001) Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am J Physiol Cell Physiol 280:C1204-1214
15. Frank PG, Lisanti MP (2004) Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia. Curr Opin Lipidol 15:523-529
16. Fu Y, Hoang A, Escher G, Parton RG, Krozowski Z, Sviridov D (2004) Expression of caveolin-1 enhances cholesterol efflux in hepatic cells. J Biol Chem 279:14140-14146
17. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, et al. (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98:2604-2609
18. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777
19. Hassan GS, Jasmin J-F, Schubert W, Frank PG, Lisanti MP (2004) Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43:8312-8321
20. Huo Y, Ley K (2001) Adhesion molecules and atherogenesis. Acta Physiol Scand 173:35-43
21. Kao CH, Chen JK, Kuo JS, Yang VC (1995) Visualization of the transport pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries. Atherosclerosis 116:27-41
22. Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, Hirata K, et al. (2001) Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler Thromb Vasc Biol 21:201-207
23. Lee WC, Chao WT, Yang VC (2001) Effects of high-cholesterol diet on the interendothelial clefts and the associated junctional complexes in rat aorta. Atherosclerosis 155:307-312
24. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, et al. (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126:111-126
25. Lupu F, Danaricu I, Simionescu N (1987) Development of intracellular lipid deposits in the lipid-laden cells of atherosclerotic lesions. Atherosclerosis 67:127-142
26. Matveev S, van der Westhuyzen DR, Smart EJ (1999) Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J Lipid Res 40:1647-1654
27. Palade GE (1953) Fine structure of blood capillaries. J Appl Phys 24:1424
28. Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M, Sowa G, et al. (2003) Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 23:1521-1527
29. Piech A, Massart PE, Dessy C, Feron O, Havaux X, Morel N, Vanoverschelde JL, et al. (2002) Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 282:H219-231
30. Ratajczak P, Damy T, Heymes C, Oliviero P, Marotte F, Robidel E, Sercombe R, et al. (2003) Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. Cardiovasc Res 57:358-369
31. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaiuso F, et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38138
32. Ross R (1986) The pathogenesis of atherosclerosis-an update. N Engl J Med 314:488-500
33. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
34. Ross R (1997) Cellular and molecular studies of atherosclerosis. Atherosclerosis 131(suppl):S3-4
35. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
36. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, et al. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable heterooligomeric complex in vivo. J Biol Chem 272:29337-29346
37. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, et al. (1996) Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-6522
38. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, et al. (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19:7289-7304
39. Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K (1996) Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 8:817-821
40. Uemura S, Fathman CG, Rothbard JB, Cooke JP (2000) Rapid and efficient vascular transport of arginine polymer inhibits myointimal hyperplasia. Circulation 102:2629-2635
41. Zulu A, Buxton BF, Black MJ, Ming Z, Cameron A, Hare DL (2006) The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels. J Histochem Cytochem 54:151-159